tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

X4 Pharmaceuticals Inc

XFOR
Add to Watchlist
3.980USD
-0.020-0.50%
Close 07-31 16:00（ET）Quotes delayed by 15 min
375.39MMarket Cap
LossP/E TTM

X4 Pharmaceuticals Inc

3.980
-0.020-0.50%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

XFOR Financials

See X4 Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

X4 Pharmaceuticals Inc Earnings Date

Latest Release
May 6, 2026
EPS / Forecast
-0.21/-0.20
Revenue / Forecast
2.71M/3.20M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
35.11M
1273.21%
EPS(YoY)
-1.87
66.49%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-113.36%-0.16
95.53%-0.26
78.37%-1.19
-125.54%-3.47
115.45%1.20
-104.11%-5.89
-1461.45%-5.48
237.25%13.60
-57.29%-7.77
66.58%-2.88
---0.35
---9.91
---4.94
---8.63
---39.61
----
----
----
----
----
Revenue
-90.60%2.71M
79.08%2.57M
215.18%1.76M
250.44%1.97M
--28.81M
--1.43M
--560.00K
--563.00K
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
Net Profit
-7277.66%-20.24M
39.92%-23.93M
18.75%-29.82M
-128.34%-25.74M
100.54%282.00K
-108.16%-39.82M
-1492.02%-36.70M
263.04%90.83M
-115.51%-51.77M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
18.96%-29.10M
-8.42%-21.87M
-8.02%-21.21M
10.00%-24.22M
-95.17%-35.91M
-15.62%-20.18M
-29.68%-19.64M
Net Margin
-76453.98%-747.45%
66.45%-931.66%
74.22%-1689.24%
-108.09%-1304.66%
--0.98%
---2776.92%
---6552.86%
--16133.75%
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
-6.83%77.92%
8.72%85.83%
34.73%80.11%
59.31%83.48%
--83.63%
--78.94%
--59.46%
--52.40%
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
-51.33%28.31%
-49.00%26.27%
10.15%46.51%
102.43%72.11%
19.03%58.17%
38.98%51.50%
34.69%42.22%
89.49%35.62%
87.76%48.87%
71.50%37.06%
--31.35%
--18.80%
--26.03%
--21.61%
--29.41%
----
----
----
----
----
Income Statement
Revenue
-90.60%2.71M
79.08%2.57M
215.18%1.76M
250.44%1.97M
--28.81M
--1.43M
--560.00K
--563.00K
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
Operating profit
-115.04%-20.31M
33.64%-23.70M
20.26%-27.51M
22.61%-26.23M
74.68%-9.44M
-41.73%-35.72M
-26.77%-34.50M
-31.36%-33.90M
-27.25%-37.29M
1.48%-25.20M
-35.03%-27.21M
-25.45%-25.80M
-34.56%-29.30M
-32.54%-25.58M
-5.41%-20.15M
-8.28%-20.57M
-21.42%-21.78M
-9.30%-19.30M
-12.60%-19.12M
-29.60%-19.00M
Net Profit
-7277.66%-20.24M
39.92%-23.93M
18.75%-29.82M
-128.34%-25.74M
100.54%282.00K
-108.16%-39.82M
-1492.02%-36.70M
263.04%90.83M
-115.51%-51.77M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
18.96%-29.10M
-8.42%-21.87M
-8.02%-21.21M
10.00%-24.22M
-95.17%-35.91M
-15.62%-20.18M
-29.68%-19.64M
Balance Sheet
Current assets
152.86%241.98M
133.19%261.58M
-7.11%132.81M
-58.42%72.94M
9.58%95.70M
-8.11%112.17M
-3.31%142.97M
18.81%175.42M
-11.09%87.33M
-5.13%122.08M
72.51%147.87M
180.78%147.65M
38.57%98.22M
46.43%128.68M
6.22%85.72M
-48.13%52.59M
-40.91%70.88M
5.49%87.88M
-14.07%80.70M
-7.75%101.37M
Total current liabilities
-8.16%23.77M
-21.66%25.76M
-19.66%23.51M
-20.78%22.90M
9.95%25.88M
43.81%32.88M
15.04%29.26M
29.89%28.90M
20.83%23.54M
2.41%22.86M
-11.43%25.43M
1.13%22.25M
30.15%19.48M
59.20%22.32M
117.00%28.71M
67.70%22.00M
2.03%14.97M
17.37%14.02M
0.40%13.23M
21.70%13.12M
Total assets
107.89%270.28M
98.34%290.46M
-8.20%163.56M
-50.07%105.17M
15.89%130.01M
-0.55%146.45M
2.81%178.16M
21.46%210.61M
-9.83%112.18M
-5.35%147.26M
52.81%173.29M
114.02%173.40M
24.87%124.41M
32.78%155.59M
-5.90%113.41M
-42.81%81.02M
-38.13%99.63M
-4.63%117.18M
-9.47%120.52M
-0.61%141.66M
Total liabilities
-4.89%101.83M
-16.19%104.17M
-14.01%101.94M
-12.88%101.20M
-3.67%107.07M
29.26%124.30M
12.15%118.54M
9.73%116.16M
52.82%111.15M
17.94%96.16M
105.01%105.70M
107.80%105.86M
45.72%72.73M
54.53%81.53M
-0.54%51.56M
-2.86%50.95M
-7.74%49.91M
5.38%52.76M
19.39%51.84M
39.30%52.45M
Total equity
634.18%168.45M
741.08%186.29M
3.35%61.62M
-95.80%3.97M
2114.67%22.94M
-56.65%22.15M
-11.80%59.62M
39.85%94.45M
-98.00%1.04M
-30.99%51.10M
9.29%67.59M
124.57%67.53M
3.95%51.68M
14.96%74.05M
-9.94%61.85M
-66.29%30.07M
-53.51%49.71M
-11.52%64.41M
-23.44%68.68M
-14.94%89.21M
Cash Flow Statement
Net operating income
-58.47%-19.60M
52.94%-15.53M
18.25%-27.82M
1.24%-29.90M
63.19%-12.37M
-18.91%-32.99M
-63.40%-34.03M
-41.32%-30.28M
-26.72%-33.60M
-45.33%-27.75M
-7.88%-20.83M
-15.97%-21.43M
-31.06%-26.51M
-0.21%-19.09M
-35.85%-19.31M
3.77%-18.47M
-9.68%-20.23M
-8.85%-19.05M
0.82%-14.21M
-67.53%-19.20M
Net investment
713.51%19.25M
295.44%16.85M
-79.98%-28.67M
-76.14%23.11M
41.04%-3.14M
-78.38%-8.62M
-208.88%-15.93M
2083.25%96.86M
-59033.33%-5.32M
-14114.71%-4.83M
-57200.00%-5.16M
-12752.63%-4.88M
59.09%-9.00K
-161.54%-34.00K
55.00%-9.00K
55.81%-38.00K
95.56%-22.00K
95.70%-13.00K
95.97%-20.00K
-855.56%-86.00K
Net financing
--2.00K
108116.30%146.09M
--86.91M
-72.07%5.63M
--0.00
39.18%135.00K
-100.00%0.00
-70.93%20.16M
100.00%0.00
-99.84%97.00K
-59.20%21.20M
20082.13%69.34M
-142.86%-2.12M
146.82%60.64M
1270.13%51.98M
62.45%-347.00K
-91.00%4.96M
222.06%24.57M
-1464.08%-4.44M
-1521.54%-924.00K

FAQs

What is the total revenue of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 35.11M, with a year-on-year change of 2.56M.

What are the current assets of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its current assets were 261.58M, with a year-on-year change of 133.19.

What are the total assets of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total assets of X4 Pharmaceuticals Inc were 290.46M, with a year-on-year change of 98.34.

What are the total liabilities of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of X4 Pharmaceuticals Inc were 104.17M, with a year-on-year change of -16.19.

What is the total equity of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its total equity of X4 Pharmaceuticals Inc was 186.29M, with a year-on-year change of 741.08.

What is the net operating income of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net operating income of X4 Pharmaceuticals Inc was -86.88M, with a year-on-year change of 38.56.

What is the net investment of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net investment of X4 Pharmaceuticals Inc was 8.15M, with a year-on-year change of -87.83.

What is the net financing of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net financing of X4 Pharmaceuticals Inc was 238.63M, with a year-on-year change of 1075.85.

What is the Earnings Per Share (EPS) of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.87, with a year-on-year change of 66.49.

What is the net income of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net income was -79.20M, with a year-on-year change of -111.48.

What is the net margin of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -225.55, with a year-on-year change of 84.60.

What is the gross margin of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 83.60, with a year-on-year change of 21.46.

What is the debt-to-asset ratio of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 26.27, with a year-on-year change of -49.00.

What is the Return on Equity (ROE) of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -75.99, with a year-on-year change of 25.68.

What is the Return on Assets (ROA) of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -36.25, with a year-on-year change of -42.16.

What is the operating profit of X4 Pharmaceuticals Inc?

According to X4 Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -86.88M, with a year-on-year change of 38.56.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy